• AMJ Global Technology posted a net loss of USD 934,274 for the three months ended Aug. 31, 2025, widening from USD 50,825 a year earlier.
• Revenue from related parties rose to USD 232 from USD 8, while operating expenses fell to USD 36,493 from USD 50,833.
• Other expense climbed to USD 898,013 from no expense a year earlier, including an impairment loss of USD 886,232 tied to revaluation of Medicare contract assets.
• For the nine months ended Aug. 31, 2025, net loss widened to USD 1.07 million from USD 47,484, as other expense increased to USD 914,367 from other income of USD 98,109.
• Cash slipped to USD 110 from USD 226, while working capital deficiency deepened to USD 1.24 million from USD 195,383.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. AMJ Global Technology published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001477932-26-002852), on May 08, 2026, and is solely responsible for the information contained therein.